Compare IXHL & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | IXHL | ABLV |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | Australia | China |
| Employees | 12 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0M | 44.9M |
| IPO Year | 2024 | 2022 |
| Metric | IXHL | ABLV |
|---|---|---|
| Price | $3.32 | $0.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 70.6K | 25.1K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.54 |
| 52 Week High | $6.39 | $1.30 |
| Indicator | IXHL | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 50.22 |
| Support Level | $3.07 | $0.63 |
| Resistance Level | $3.98 | $1.22 |
| Average True Range (ATR) | 0.19 | 0.11 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 7.46 | 22.87 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.